Session: SUN 459-496-Thyroid Neoplasia & Case Reports
Poster Board SUN-474
Methods: We randomized 74 early stage PTC patients in a 1:1 ratio, to either exposure to a computerized decision aid (DA), or no DA, around the time of post-surgical RAI treatment decision-making. All patients received usual care and counselling from their treating physicians. We contacted patients by phone more than a year after randomization and evaluated patients’ perceptions on how well informed they were about the decision to take RAI or not. Participants were asked to grade, on a 5-point Likert scale, their level of agreement with 4 questions, including whether they made an informed choice, whether they were aware of the available choices, whether they knew the benefits of the treatment, and whether they knew the risks and side effects of the treatment. We compared scores between the DA and no DA groups, using unpaired Student’s t-tests.
Results: To date, we have completed follow-up with 70/74 (95%) of the study population, including data from 58 women and 12 men, a mean of 16.5 months after randomization (standard deviation, SD 2.2). Patients in the DA group had significantly superior measurements, compared with the no DA group, for the perceptions on: a) having made an informed RAI treatment choice (p=0.008), b) being aware of the treatment choices (p=0.009), c) knowing the benefits of RAI treatment (p=0.020), and d) knowing the risks and side effects of RAI treatment (p=0.001).
Conclusions: A computerized DA improves patients’ perceptions on feeling well-informed about RAI treatment choice, when evaluated at long-term follow-up. Decision aids may be helpful adjuncts, in addition to physician counselling, for educating low risk PTC patients about RAI treatment options.
Nothing to Disclose: AMS, AN, SS, JDB, RWT, LR, SZE, DPG
*Please take note of The Endocrine Society's News Embargo Policy at http://www.endo-society.org/endo2013/media.cfm
See more of: Abstracts - Orals, Featured Poster Presentations, and Posters